Table 4.
Mean (±SD) of Transferrin (mg/dl), Ferritin (ng/ml) and Iron in Blood (μg/dl) concentration of all participants such as participants without and with anemia at month 1, 6 and 12 of intervention time
| All patients (n = 99) | p-val. (a) | no anemia (n = 70) | p-val.(a) | Anemia (n = 29) | p-val.(a) | |
|---|---|---|---|---|---|---|
| Transferrin (mg/dl) | ||||||
| Month 1 | 218.54 (±47.67) | 222.91 (±41.32) | 207.78 (±60.10) | |||
| Month 6 | 224.09 (±44.97) | 226.82 (±41.77) | 217.35 (±52.24) | |||
| Month 12 | 230.50 (±48.01) | 0.009* | 229.25 (±41.13) | 0.138 | 233.53 (±60.78) | 0.006* |
| Ferritin (ng/ml) | ||||||
| Month 1 | 149.61 (±134.61) | 150.28 (±133.5) | 147.88 (±139.1) | |||
| Month 6 | 144.79 (±125.85) | 142.82 (±126.4) | 149.64 (±126.6) | |||
| Month 12 | 158.32 (±141.32) | 0.230 | 164.38 (±144.4) | 0.047* | 143.60 (±134.7) | 0.712 |
| Iron in Blood (μg/dl) | ||||||
| Month 1 | 70.55 (±26.65) | 76.37 (±27.29) | 56.51 (±19.03) | |||
| Month 6 | 69.80 (±26.38) | 74.72 (±26.12) | 57.93 (±23.39) | |||
| Month 12 | 68.00 (±23.86) | 0.213 | 70.13 (±24.13) | 0.117 | 62.93 (±22.82) | 0.867 |
(a) Friedmann Rang Analysis; Significance* = p < 0.05